ArticleBMC gastroenterology2024

ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.

Tao Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.